Mitigation of Anxiety, Agitation, and Pain in Critically Ill Patients

References (64)

1. Marra A, Ely EW, Pandharipande PP, et al. The ABCDEF bundle in critical care. Crit Care Clin. 2017;33(2):225–243. CrossRef
2. Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825–e873.
3. Ramnarain D, Aupers E, Den Oudsten B, et al. Post Intensive Care Syndrome (PICS): an overview of the definition, etiology, risk factors, and possible counseling and treatment strategies. Expert Rev Neurother. 2021;21(10):1159–1177. CrossRef
4. Trescot AM, Datta S, Lee M, et al. Opioid pharmacology. Pain Physician. 2008;11(2 suppl):S133–S153.
5. Kosten T, George T. The neurobiology of opioid dependence: implications for treatment. SPP. 2002;1(1):13–20. PubMed CrossRef
6. DailyMed - DIPRIVAN- propofol injection, emulsion. 2023. Accessed October 1, 2024. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e3105799-a4b6-f3f4-e6e2-b2b29bbdb538
7. DailyMed - MIDAZOLAM HYDROCHLORIDE injection, solution. 2023. Accessed October 1, 2024. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1abda8b8-48a8-4995-af86-39220d1aa240
8. Gertler R, Brown HC, Mitchell DH, et al. Dexmedetomidine: a novel sedative analgesic agent. Proc (Bayl Univ Med Cent). 2001;14(1):13–21. PubMed CrossRef
9. Scott-Warren V, Sebastian J. Dexmedetomidine: its use in intensive care medicine and anaesthesia. BJA Educ. 2016;16(7):242–246. CrossRef
10. Dutta A, Sethi N, Sood J, et al. The effect of dexmedetomidine on propofol requirements during anesthesia administered by bispectral index-guided closed loop anesthesia delivery system: a randomized controlled study. Anesth Analg. 2019;129(1):84–91. CrossRef
11. Hughes CG, McGrane S, Pandharipande PP. Sedation in the intensive care setting. Clin Pharmacol. 2012;4:53–63. CrossRef
12. DailyMed - DEXMEDETOMIDINE HYDROCHLORIDE injection, solution, concentrate DEXMEDETOMIDINE HYDROCHLORIDE IN DEXTROSE dexmedetomidine hydrochloride injection. 2021. Accessed October 1, 2024. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d2710f2-ee47-4114-ab5c-8dca74cdcb8d
13. Martyn JAJ, Mao J, Bittner EA. Opioid tolerance in critical illness. N Engl J Med. 2019;380(4):365–378. CrossRef
14. Devabhakthuni S, Armahizer MJ, Dasta JF, et al. Analgosedation: a paradigm shift in intensive care unit sedation practice. Ann Pharmacother. 2012;46(4):530–540. PubMed CrossRef
15. Singh A, Anjankar AP. Propofol-related infusion syndrome: a clinical review. Cureus. 2022;14(10):e30383.
16. Terry K, Blum R, Szumita P. Evaluating the transition from dexmedetomidine to clonidine for agitation management in the intensive care unit. SAGE Open Med. 2015;3:2050312115621767. PubMed CrossRef
17. Eadie R, McKenzie CA, Hadfield D, et al. Opioid, sedative, preadmission medication and iatrogenic withdrawal risk in UK adult critically ill patients: a point prevalence study. Int J Clin Pharm. 2023;45(5):1167–1175. CrossRef
18. Fox MA, Carothers C, Dircksen KK, et al. Prevalence and risk factors for iatrogenic opioid withdrawal in medical critical care patients. Crit Care Explor. 2023;5(5):e0904. CrossRef
19. Lamey PS, Landis DM, Nugent KM. Iatrogenic opioid withdrawal syndromes in adults in intensive care units: a narrative review. J Thorac Dis. 2022;14(6):2297–2308. CrossRef
20. Imray JM, Hay A. Withdrawal syndrome after propofol. Anaesthesia. 1991;46(8):704. PubMed CrossRef
21. Tobias JD. Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med. 2000;28(6):2122–2132. PubMed CrossRef
22. Pandharipande P, Shintani A, Peterson J, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology. 2006;104(1):21–26. PubMed CrossRef
23. Pathan S, Kaplan JB, Adamczyk K, et al. Evaluation of dexmedetomidine withdrawal in critically ill adults. J Crit Care. 2021;62:19–24. CrossRef
24. Bouajram RH, Bhatt K, Croci R, et al. Incidence of dexmedetomidine withdrawal in adult critically ill patients: a pilot study. Crit Care Explor. 2019;1(8):e0035. CrossRef
25. Glaess SS, Attridge RL, Christina Gutierrez G. Clonidine as a strategy for discontinuing dexmedetomidine sedation in critically ill patients: a narrative review. Am J Health Syst Pharm. 2020;77(7):515–522. PubMed CrossRef
26. Gagnon DJ, Riker RR, Glisic EK, et al. Transition from dexmedetomidine to enteral clonidine for ICU sedation: an observational pilot study. Pharmacotherapy. 2015;35(3):251–259. PubMed CrossRef
27. Jiang S, Hernandez M, Burke H, et al. A retrospective analysis of guanfacine for the pharmacological management of delirium. Cureus. 2023;15(1):e33393.
28. Morales Castro D, Dresser L, Granton J, et al. Pharmacokinetic alterations associated with critical illness. Clin Pharmacokinet. 2023;62(2):209–220. CrossRef
29. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371(9607):126–134. PubMed CrossRef
30. Maldonado JR. Delirium pathophysiology: an updated hypothesis of the etiology of acute brain failure. Int J Geriat Psychiatry. 2018;33(11):1428–1457. PubMed CrossRef
31. Trzepacz PT. The neuropathogenesis of delirium. A need to focus our research. Psychosomatics. 1994;35(4):374–391. PubMed CrossRef
32. Usuki M, Matsuoka Y, Nishi D, et al. Potential impact of propofol immediately after motor vehicle accident on later symptoms of posttraumatic stress disorder at 6-month follow up: a retrospective cohort study. Crit Care. 2012;16(5):R196. PubMed CrossRef
33. Westbrook RF, Greeley JD, Nabke CP, et al. Aversive conditioning in the rat: effects of a benzodiazepine and of an opioid agonist and antagonist on conditioned hypoalgesia and fear. J Exp Psychol Anim Behav Process. 1991;17(3):219–230. PubMed CrossRef
34. Vogt KM, Pryor KO. Anesthesia and the neurobiology of fear and posttraumatic stress disorder. Curr Opin Anaesthesiol. 2022;35(5):593–599. CrossRef
35. Duprey MS, Dijkstra-Kersten SMA, Zaal IJ, et al. Opioid use increases the risk of delirium in critically ill adults independently of pain. Am J Respir Crit Care Med. 2021;204(5):566–572. CrossRef
36. Kok L, Slooter AJ, Hillegers MH, et al. Benzodiazepine use and neuropsychiatric outcomes in the ICU: a systematic review. Crit Care Med. 2018;46(10):1673–1680. CrossRef
37. Gaudreau JD, Gagnon P. Psychotogenic drugs and delirium pathogenesis: the central role of the thalamus. Med Hypotheses. 2005;64(3):471–475. PubMed CrossRef
38. Lewis K, Alshamsi F, Carayannopoulos KL, et al. Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trials. Intensive Care Med. 2022;48(7):811–840. CrossRef
39. Maldonado JR, Wysong A, Van Der Starre PJA, et al. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 2009;50(3):206–217. PubMed CrossRef
40. Flükiger J, Hollinger A, Speich B, et al. Dexmedetomidine in prevention and treatment of postoperative and intensive care unit delirium: a systematic review and meta-analysis. Ann Intensive Care. 2018;8(1):92.
41. Kandel ER, Koester J, Mack S, et al, eds. Principles of Neural Science. Sixth edition. McGraw Hill; 2021.
42. Elliott R, McKinley S, Cistulli P, et al. Characterisation of sleep in intensive care using 24-hour polysomnography: an observational study. Crit Care. 2013;17(2):R46. PubMed CrossRef
43. Akeju O, Hobbs LE, Gao L, et al. Dexmedetomidine promotes biomimetic non rapid eye movement stage 3 sleep in humans: a pilot study. Clin Neurophysiol. 2018;129(1):69–78. PubMed CrossRef
44. Nelson LE, Lu J, Guo T, et al. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003;98(2):428–436. PubMed CrossRef
45. Liu H, Wei H, Qian S, et al. Effects of dexmedetomidine on postoperative sleep quality: a systematic review and meta-analysis of randomized controlled trials. BMC Anesthesiol. 2023;23(1):88. CrossRef
46. Hong KS, Kim NR, Song SH, et al. Cycling of dexmedetomidine may prevent delirium after liver transplantation. Transpl Proc. 2018;50(4):1080–1082. CrossRef
47. Weinhouse GL, Schwab RJ. Sleep in the critically ill patient. Sleep. 2006;29(5):707–716. CrossRef
48. Murphy M, Bruno MA, Riedner BA, et al. Propofol anesthesia and sleep: a high density EEG study. Sleep. 2011;34(3):283–91A. PubMed CrossRef
49. Cutrufello NJ, Ianus VD, Rowley JA. Opioids and sleep. Curr Opin Pulm Med. 2020;26(6):634–641. CrossRef
50. Jones C, Griffiths RD, Humphris G. Disturbed memory and amnesia related to intensive care. Memory. 2000;8(2):79–94. PubMed CrossRef
51. Ressler KJ, Berretta S, Bolshakov VY, et al. Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits. Nat Rev Neurol. 2022;18(5):273–288. CrossRef
52. Costa JBD, Marcon SS, Macedo CRLD, et al. Sedation and memories of patients subjected to mechanical ventilation in an intensive care unit. Rev Bras Ter Intensiva. 2014;26(2):122–129. PubMed CrossRef
53. Guina J, Rossetter SR, DeRHODES BJ, et al. Benzodiazepines for PTSD: a systematic review and meta-analysis. J Psychiatr Pract. 2015;21(4):281–303.
54. Yu Y, Li Y, Han D, et al. Effect of dexmedetomidine on posttraumatic stress disorder in patients undergoing emergency trauma surgery: a randomized clinical trial. JAMA Netw Open. 2023;6(6):e2318611.
55. Maldonado JR. Acute brain failure: pathophysiology, diagnosis, management, and sequelae of delirium. Crit Care Clin. 2017;33(3):461–519.
56. Kim J, Van Zyl E, Benitez-Lopez M, et al. Use of guanfacine as an alternative to dexmedetomidine for sedation and agitation management in the intensive care unit. J Psychosomatic Res. 2020;133:110062. CrossRef
57. Kleinpell R, Heyland DK, Lipman J, et al. Patient and family engagement in the ICU: report from the task force of the World Federation of Societies of Intensive and Critical Care Medicine. J Crit Care. 2018;48:251–256. CrossRef
58. Golino AJ, Leone R, Gollenberg A, et al. Impact of an active music therapy intervention on intensive care patients. Am J Crit Care. 2019;28(1):48–55. CrossRef
59. van Veen S, Drenth H, Hobbelen H, et al. Non-pharmacological interventions feasible in the nursing scope of practice for pain relief in palliative care patients: a systematic review. Palliat Care Soc Pract. 2024;18:26323524231222496.
60. Schmidt B, Schneider J, Deffner T, et al. Hypnotic suggestions of safety improve well-being in non-invasively ventilated patients in the intensive care unit. Intensive Care Med. 2021;47(4):485–486. CrossRef
61. Skrobik Y, Ahern S, Leblanc M, et al. Protocolized intensive care unit management of analgesia, sedation, and delirium improves analgesia and subsyndromal delirium rates. Anesth Analg. 2010;111(2):451–463. PubMed CrossRef
62. Parker AM, Sricharoenchai T, Raparla S, et al. Posttraumatic stress disorder in critical illness survivors: a metaanalysis. Crit Care Med. 2015;43(5):1121–1129. PubMed CrossRef
63. Pask S, Dell’Olio M, Murtagh FEM, et al. The effects of opioids on cognition in older adults with cancer and chronic noncancer pain: a systematic review. J Pain Symptom Manage. 2020;59(4):871–893.e1.
64. Dhingra L, Ahmed E, Shin J, et al. Cognitive effects and sedation. Pain Med. 2015;16(suppl 1):S37–S43. CrossRef